Table 4 Risk factors of liver enzyme elevation during statin therapy by multivariate analysis
From: A prospective study of hepatic safety of statins used in very elderly patients
Factor | Wald χ2 | P value | Odds ratio | 95% CI for OR | |
|---|---|---|---|---|---|
Lower | Upper | ||||
Hepatitis B | 21.469 | .000 | 12.830 | 4.360 | 37.759 |
Alcohol abuse | 8.177 | .004 | 2.736 | 1.373 | 5.454 |